Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Diversicare to Present at the Sidoti & Company Fall 2017 Conference


Posted on: 12 Sep 17

BRENTWOOD, Tenn., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Diversicare Healthcare, Inc. (Nasdaq:DVCR), a premier operator of long-term care services, announced today that it will be presenting at the Sidoti & Company Fall 2017 Conference on September 28th at the New York Marriott Marquis hotel in Times Square, New York City. Kelly Gill, President and Chief Executive Officer, and Jay McKnight, Chief Financial Officer, will be presenting at 2:30PM EDT, as well as meeting with investors.

Sidoti & Company is the preeminent, institutional-quality equity research provider on Wall Street covering small- and micro-cap equities. We are building interest and visibility into the most overlooked, undervalued segment of the equity market. Sidoti & Company aims to unite small- and micro-cap companies together with quality investors. 

About Diversicare (Nasdaq:DVCR)

Diversicare provides long-term care services to patients in 77 skilled nursing centers containing 8,556 licensed beds, primarily in the Southeast, Midwest and Southwest. For additional information about the Company, visit Diversicare's web site: www.DVCR.com

About Sidoti & Company

Sidoti & Company, LLC is Wall Street’s preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. We cover over 250 companies across a range of industries. The companies covered by our traditional research typically have a history of profitability, maintain strong balance sheets, and tend to have limited, if any, coverage by other Wall Street firms.

Our approach affords institutional investor clients a combination of high-quality research, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. We serve nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. We believe that these asset managers are generally underserved by other larger brokerage firms that typically target larger managers.

Sidoti also hosts a fee-based biannual conference in New York, and is a provider of company sponsored research.

We are a broker-dealer registered with the SEC and a FINRA member firm. We provide a broad range of securities-related services. In addition to our high-quality research, our sales and trading services are distinguished by prompt execution, a competitive commission structure and access to smart order routing that utilizes all available sources of liquidity. From time to time, we are invited to participate as an underwriter, dealer, placement agent or initial purchaser in securities offerings for issuers for which we provide research coverage. Given our knowledge of the companies we cover, we believe that we are able to contribute to these capital-raising transactions. We also assist our issuers with stock repurchase programs, block trades and organized (Rule 10b5-1) trading plans.

For those interested in attending, please contact Caitlin Adams at conference@sidoti.com or visit https://www.meetmax.com/sched/event_43487/~public/conference_register.html?event_id=43487&bank_access=0  for more information.

Company Contact:
Kelly J. Gill
Chief Executive Officer
615-771-7575

Investor Relations:
James R. McKnight, Jr.
Chief Financial Officer
615-771-7575

GlobeNewswire
globenewswire.com

Last updated on: 13/09/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.